0000000000406818

AUTHOR

Andreea Varga

showing 2 related works from this author

A phase I/Ib study evaluating GDC-0077 (inavolisib) + palbociclib (palbo) + fulvestrant in patients (pts) with PIK3CA-mutant (mut), hormone receptor-…

2021

FulvestrantHormone receptorbusiness.industryMutantHER2 negativeCancer researchmedicineIn patientPalbociclibmedicine.diseasebusinessMetastatic breast cancermedicine.drugSenologie - Zeitschrift für Mammadiagnostik und -therapie
researchProduct

336P PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HE…

2020

Breast cancerOncologybusiness.industryHormone receptorHER2 negativeCancer researchMedicineHematologybusinessmedicine.diseasePI3K/AKT/mTOR pathwayAnnals of Oncology
researchProduct